Search results
COVID-19 vaccine effectiveness and fewer common side effects most important factors in whether...
Medical Xpress· 5 days agoIn contrast, timing of COVID-19 and influenza vaccines and their type have little influence on...
Backlogged: Few cases finished after millions spent investigating COVID vaccine claims
Valley News Live· 7 hours agoOn the extremely rare occasions that a vaccine meant to protect public health harms a patient, the...
The path to a better tuberculosis vaccine runs through Montana
Medical Xpress· 9 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
Can nasal Neosporin fight COVID? Surprising new research suggests it works
Salon via Yahoo News· 3 days agoNeosporin Tim Boyle/Getty Images Four years ago, when COVID-19 first began to spread globally, it...
Uveitis History Linked to Recurrence After COVID Vaccination
MedPage Today· 5 days ago(HR 2.07, 95% CI 1.40-3.07). "These findings suggest that there was an elevated risk of uveitis...
Cervical cancer vaccine roll-out shows efficacy in reducing cervical cancer and other HPV-related...
Medical Xpress· 11 hours agoWith the creation of safe and efficacious vaccines to target human papillomavirus in the first...
X’s Community Notes Accurately Corrected Vaccine Misinformation 97% Of The Time Last Year, Study...
Forbes· 6 days agoThe relatively new community notes feature on X, formerly known as Twitter, almost always featured...
How mRNA Is Rewriting the Rules of Cancer Treatment
SciTechDaily· 5 days agoMIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful...
27pc spike in anti-vaccine posts on X after Covid jabs were available: Study
Investing.com· 2 days ago27pc spike in anti-vaccine posts on X after Covid jabs were available: Study
mRNA vaccine tech can be harnessed to prevent deadly diseases: Report
Investing.com· 6 days agomRNA vaccine tech can be harnessed to prevent deadly diseases: Report